The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
14 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,789,038 in first-year total cost, median $224,992.
Most frequent study sections
- Special Emphasis Panel[ZRG1 ETTN-M (11)]5
- Special Emphasis Panel[ZRG1 ETTN-L (11)]3
- Special Emphasis Panel[ZRG1 ETTN-P (13)]2
- Special Emphasis Panel[ZRG1 RPHB-C (11)]2
- Special Emphasis Panel[ZRG1 RPHB-R (12)]2
Most frequent institutions
- COGNITION THERAPEUTICS, INC.2
- AFASCI, INC.1
- AFRAXIS 2.0, INC.1
- ASURAGEN, INC.1
- CENNA BIOSCIENCES, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Development of patented tricyclic pyrones molecules for the treatment of Alzheimer’s Disease2R44AG043203-03 | XIE, XINMIN SIMON | AFASCI, INC., CA | $973,076 | ZRG1 |
| 2017 | Brain-enriched microRNAs detectable in plasma as biomarkers of Alzheimer's disease2R44AG044860-04 | UMANSKY, SAMUIL R | DIAMIR, LLC, NJ | $916,749 | ZRG1 |
| 2017 | Caring Light for Family Caregivers1R44AG055209-01A1 | KAJIYAMA, BRUNO | PHOTOZIG, INC., CA | $299,133 | ZRG1 |
| 2017 | Development of a unified Alzheimer's disease test that combines high resolution analysis of TOMM40 and Apolipoprotein E for improved risk estimates1R43AG056212-01 | STATT, SARAH NICOLE | ASURAGEN, INC., TX | $224,984 | ZRG1 |
| 2017 | Structural variants of Abeta oligomer displacing small molecules1R44AG055206-01A1 | CATALANO, SUSAN M | COGNITION THERAPEUTICS, INC., PA | $224,147 | ZRG1 |
| 2017 | Rapid circuit-level dendritic spine morphometric analysis for in vivo pharmacology in CNS drug discovery1R43AG056236-01 | REX, CHRISTOPHER STEVEN | AFRAXIS 2.0, INC., CA | $204,508 | ZRG1 |
| 2016 | A Humanized Swine Model for Alzheimer's Disease1R43AG055178-01 | WATSON, ADRIENNE LEIGH | RECOMBINETICS, INC., MN | $358,338 | ZRG1 |
| 2016 | Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer’s in at-risk Older Adults1R44AG055176-01 | PLOCHER, TOMYU, FANG | MOAI TECHNOLOGIES, LLC, MN | $248,493 | ZRG1 |
| 2016 | Building a Low Cost High Density Data Gathering Platform For Studying High-functioning Elders1R43AG055190-01 | KAMINSKY , MIKEPENTLAND, ALEX | HUMAN PROJECT, INC., NY | $240,006 | ZRG1 |
| 2016 | Small molecule therapeutics for Alzheimer's Disease1R43AG055182-01 | DEWJI, NAZNEEN N | CENNA BIOSCIENCES, INC., CA | $225,000 | ZRG1 |
| 2016 | Novel assays for assessing protein-protein interactions in Alzheimer's disease1R43AG055250-01 | BUTT, TAUSEEF R. | LIFESENSORS, INC., PA | $224,674 | ZRG1 |
| 2016 | Lead Optimization of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease1R44AG055205-01 | GREENBERG, MILTON L | VIVREON BIOSCIENCES, LLC, CA | $222,453 | ZRG1 |
| 2016 | Target Engagement Biomarkers for Alzheimer's Therapeutics1R44AG055247-01 | CATALANO, SUSAN M | COGNITION THERAPEUTICS, INC., PA | $222,004 | ZRG1 |
| 2016 | Mobile Application to Deliver Personalized Nutrition for the Prevention of Alzheimer's Disease1R43AG055203-01 | SHEN, LI | GENBEN LIFESCIENCES CORPORATION, CA | $205,473 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.